(Medical Xpress)—Drugs that boost the function of a specific type of neurotransmitter receptor may provide benefit to patients with the second most common type of dementia, Frontotemporal dementia, known as FTD, according to research by scientists at the University of Alabama at Birmingham published today in the Journal of Neuroscience.
A new study headed by a research group from Aarhus University Hospital and Aarhus University in Denmark has found new molecular sub-groups in early stages of bladder cancer. This improves the understanding of why some tumours develop aggressively and this discovery may lead to optimized treatment.
A new study on monk parakeets reveals a sophisticated social structure with layers of relationships and complex interactions. Credit: Steve Baldwin, brooklynparrots.com - Related news release: Being social: Learning from the behavior of birds - http://www.eurekalert.org/pub_releases/2014-09/nifm-bsl091114.php